Cargando…

Height, but not binding epitope, affects the potency of synthetic TCR agonists

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wilhelm, Kiera B., Morita, Shumpei, McAffee, Darren B., Kim, Sungi, O’Dair, Mark K., Groves, Jay T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Biophysical Society 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633816/ https://www.ncbi.nlm.nih.gov/pubmed/34742402 http://dx.doi.org/10.1016/j.bpj.2021.10.022

Ejemplares similares

Height, but not binding epitope, affects the potency of synthetic TCR agonists
por: Wilhelm, Kiera B., et al.
Publicado: (2021)

Discrete LAT condensates encode antigen information from single pMHC:TCR binding events
por: McAffee, Darren B., et al.
Publicado: (2022)

Breakage of the oligomeric CaMKII hub by the regulatory segment of the kinase
por: Karandur, Deepti, et al.
Publicado: (2020)

Allosteric inhibition of the T cell receptor by a designed membrane ligand
por: Ye, Yujie, et al.
Publicado: (2023)

Direct single molecule measurement of TCR triggering by agonist pMHC in living primary T cells
por: O'Donoghue, Geoff P, et al.
Publicado: (2013)

Synthesis of Highly Functionalized Tri- and Tetrasubstituted Alkenes via Pd-Catalyzed 1,2-Hydrovinylation of Terminal 1,3-Dienes
por: Saini, Vaneet, et al.
Publicado: (2015)

The Clerical Resolution Online Widget (CROW): creating open-source software to make clerical review easier.
por: O'Dair, Hannah, et al.
Publicado: (2022)

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering
por: Heckel, Franziska, et al.
Publicado: (2022)

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
por: Craft, Sam, et al.
Publicado: (2021)

Rapid TCR:Epitope Ranker (RAPTER): a primary human T cell reactivity screening assay pairing epitope and TCR at single cell resolution
por: Deering, Raquel P., et al.
Publicado: (2023)

TCR mimic compounds for pHLA targeting with high potency modalities in oncology
por: Gerber, Hans-Peter, et al.
Publicado: (2022)

Relative potency estimation for synthetic petroleum skin carcinogens.
por: Holland, J M, et al.
Publicado: (1981)

ATM-TCR: TCR-Epitope Binding Affinity Prediction Using a Multi-Head Self-Attention Model
por: Cai, Michael, et al.
Publicado: (2022)

Activation of the μ‐opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure
por: Åstrand, Anna, et al.
Publicado: (2020)

Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection
por: Shimizu, Akihisa, et al.
Publicado: (2013)

Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2018)

CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes
por: Jian, Xingxing, et al.
Publicado: (2023)

Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
por: Schmidt, Julien, et al.
Publicado: (2021)

Predicting TCR-Epitope Binding Specificity Using Deep Metric Learning and Multimodal Learning
por: Luu, Alan M., et al.
Publicado: (2021)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022)

Epitope Flexibility and Dynamic Footprint Revealed by Molecular Dynamics of a pMHC-TCR Complex
por: Reboul, Cyril F., et al.
Publicado: (2012)

2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes
por: Kolawole, Elizabeth M., et al.
Publicado: (2018)

Broad TCR Repertoire And Diverse Structural Solutions To Recognition Of An Immunodominant CD8 T Cell Epitope
por: Song, InYoung, et al.
Publicado: (2017)

Surface-Anchored Monomeric Agonist pMHCs Alone Trigger TCR with High Sensitivity
por: Ma, Zhengyu, et al.
Publicado: (2008)

The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands
por: Madrenas, Joaquín, et al.
Publicado: (1997)

Bioorthogonal Chemical Ligation Creates Synthetic Antibodies with Improved Therapeutic Potency
por: Wang, Ruixiang, et al.
Publicado: (2023)

Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic Potencies
por: Tilayov, Tal, et al.
Publicado: (2020)

The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
por: Fleri, Ward, et al.
Publicado: (2017)

Immunoprotective Leishmania major synthetic T cell epitopes
Publicado: (1990)

Advances in synthetic peptide immuno-regulatory epitopes
por: Creticos, Peter Socrates
Publicado: (2014)

Editorial: Epitope Discovery and Synthetic Vaccine Design
por: Palatnik-de-Sousa, Clarisa Beatriz, et al.
Publicado: (2018)

Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
por: Sim, Adrian Chong Nyi, et al.
Publicado: (2013)

Does provision of antenatal care in Southern Asia improve neonatal survival? A systematic review and meta-analysis
por: O'Dair, Millie A., et al.
Publicado: (2022)

T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope
por: Saeed, Mesha, et al.
Publicado: (2020)

For High Potencies
por: Fincke, B.
Publicado: (1897)

Induction and Suppression of an Autoimmune Disease by Oligomerized T Cell Epitopes: Enhanced in Vivo Potency of Encephalitogenic Peptides
por: Falk, Kirsten, et al.
Publicado: (2000)

A high potency nonformylated peptide agonist for the phagocyte N- formylpeptide chemotactic receptor
Publicado: (1994)

Methyl Substitution of a Rexinoid Agonist Improves Potency and Reveals Site of Lipid Toxicity
por: Atigadda, Venkatram R., et al.
Publicado: (2014)

Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity
por: Beesu, Mallesh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u3la6ef13g4ui20rgmn32f1eq8